Without the benefit of examination and testing, coloplast is precluded from commenting on the condition of the device or the cause of the occurrence.Should additional facts prompt us to alter or supplement any information or conclusions contained in the original mdr or in any prior supplemental reports, a follow-up report will be submitted.Coloplast has not been provided any corroborating evidence to verify the information contained in this report.
|
As reported to coloplast, though not verified, legal representative stated (b)(6) 2018 excision surgery for erosion in the midportion of the sling requiring a partial removal.(b)(6) 2019 second excision surgery for erosion on the right side of the vaginal wall.Seen in the er and subsequently admitted to the hospital in (b)(6) 2019 with complaints of pelvic and hip pain, malodorous vaginal discharge and dyspareunia.Evaluated in the er (b)(6) 2019 for complaints of pelvic pain, stress incontinence and dyspareunia.No other adverse patient effects were reported.
|
Additional information received further reported that between (b)(6) 2018 and (b)(6) 2020, the patient experienced the following: blood in the vaginal area, urethrocele repair, and removal of a vaginal nodule.Sling erosion was noted to be approximately 05-1.0 centimeters, hematuria, a wet mount positive for clue cells, ovarian cysts/follicles, pulling sensation in the abdominal cavity, dysuria, bacterial vaginosis, protruding bladder sling, difficulty voiding, mesh in the vaginal area, discomfort for her partner, limited feeling in the vagina due to multiple surgeries, pelvic floor tenderness, pink vaginal discharge, chest pain, difficulty voiding, urgency, chronic infections, a small superficial laceration, urinary tract infection, burning with urination, cystitis, patchy submucosal fibrosis, and chronic inflammation.A retroperitoneal ultrasound had normal results.
|